Clinical trial / 2006
Plant-based diet and stress reduction linked to slower PSA rise in prostate cancer
A 6-month pre-post clinical trial examined a plant-based diet combined with stress management among 14 individuals with recurrent prostate cancer. The rate of prostate-specific antigen (PSA) rise was significantly lower during the intervention than prestudy (P < .01). Among 10 evaluable patients, four experienced absolute decreases in PSA levels, and nine had reduced rates of PSA rise, with median PSA doubling time lengthening from 11.9 months prestudy to 112.3 months during the study.
- Study type
- Before-and-after trial
- Who was studied
- 14 patients with recurrent prostate cancer
- What was measured
- Prostate-specific antigen rise and doubling time
THE PAPER
Potential attenuation of disease progression in recurrent prostate cancer with plant-based diet and stress reduction.
Saxe GA, Major JM, Nguyen JY, Freeman KM, Downs TM, Salem CE. Integr Cancer Ther, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.